Director/PDMR Shareholding

Summary by AI ^BETAClose X

CRH plc has announced transactions by its Chief Executive Officer, Jim Mintern, and Company Secretary, Neil Colgan, on February 23rd and 24th, 2026. Mintern's transactions involved the vesting of 14,372 shares from a 2023 Deferred Share Award, the sale of 7,502 ordinary shares at $120.7838 on the New York Stock Exchange, and the vesting of 41,281 shares from a 2026 Restricted Share Unit Award and 61,921 shares from a 2026 Performance Share Unit Award, all outside a trading venue. Colgan's transactions included the vesting of 10,185 shares from a 2023 Performance Share Plan Award, the sale of 5,317 shares at $121.1719 and 4,868 shares at $121.4918 on the New York Stock Exchange, and the vesting of 2,031 shares from a 2026 Performance Share Unit Award and 1,354 shares from a 2026 Restricted Share Unit Award, with the latter two outside a trading venue.

Disclaimer*

CRH PLC

26 February 2026

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

Details of the person discharging managerial responsibilities/person closely associated

Name

Jim Mintern

Reason for the notification

Position/status

Chief Executive Officer, CRH plc

Initial Notification Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

CRH plc

LEI

549300MIDJNNTH068E74

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument,

type of

instrument

Identification code

Ordinary Shares of €0.32 each [ISIN: IE0001827041]

Nature of the transaction

1. Vesting of 2023 Deferred Share Award

2. Sale of Shares

3. 2026 Restricted Share Unit Award

4. 2026 Performance Share Unit Award

Price(s) and volume(s)

	Price(s)	Volume(s)
1.	n/a	14,372
2.	$120.7838	7,502
3.	n/a	41,281
4	n/a	61,921

Aggregated information

- Aggregated volume

- Price

n/a

Date of the transaction

23^rd February 2026

Place of the transaction

1.,3., & 4: Outside a Trading Venue

2. New York Stock Exchange

Additional Information

n/a

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Details of the person discharging managerial responsibilities/person closely associated

Name

Neil Colgan

Reason for the notification

Position/status

Company Secretary, CRH plc

Initial Notification Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

CRH plc

LEI

549300MIDJNNTH068E74

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument,

type of

instrument

Identification code

Ordinary Shares of €0.32 each [ISIN: IE0001827041]

Nature of the transaction

1. Vesting of 2023 Performance Share Plan Award

2. Sale of Shares

3. Sales of shares

4. 2026 Performance Share Unit Award

5. 2026 Restricted Share Unit Award

Price(s) and volume(s)

	Price(s)	Volume(s)
1.	n/a	10,185
2.	$121.1719	5,317
3.	$121.4918	4,868
4.	n/a	2,031
5.	n/a	1,354

Aggregated information

- Aggregated volume

- Price

n/a

Date of the transaction

1., 2., 4. & 5. 23^rd February 2026

3. 24^th February 2026

Place of the transaction

1., 4. & 5: Outside a Trading Venue

2. & 3: New York Stock Exchange

Additional Information

n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END